GAO Issues Scathing Review Of FDA Probe Oversight

Law360, New York (March 4, 2010, 4:30 PM EST) -- The U.S. Government Accountability Office released a report Thursday documenting a number of shortcomings within the Food and Drug Administration’s investigation unit, citing a severe lack of oversight in how the agency handles its criminal and misconduct investigations.

The GAO found that the FDA maintained little oversight of the investigations conducted by its Office of Criminal Investigations and said the unit lacks the performance monitoring necessary for the agency to evaluate its success.

“Although OCI has policies to guide its investigations of individuals and companies external...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.